logo-loader
viewEXMceuticals

EXMceuticals appoints former head of Portugal's health regulator to advisory board

Dr Eurico Castro Alves is also the founder of a European business and clinical consultancy offering guidance to the medical cannabis industry

cannabis euro
EXMceuticals also said that chief strategy officer Marc Bernier was stepping down from the role to move to a consultancy relationship

EXMceuticals Inc (CSE:EXM) has appointed the former president of Portugal’s health regulator, Dr Eurico Castro Alves, to its advisory board. 

The new advisor is also the founder of WiseHS medical and Pharmaceutical consulting, a European business and clinical consultancy that offers guidance to the medical cannabis industry. 

Vancouver-based EXMceuticals engaged WiseHS to help the firm get its cannabis R&D license for its Portuguese laboratory, CEO Jonathan Summers told shareholders. 

READ: EXMceuticals adds leading UK cannabis lawyer Nick Davis to advisory team

“(Dr Castro Alves) engagement will clearly assist the future development of EXMceuticals in Portugal,” Summers said. “He and EXM share a common goal to establish Portugal as a centre for medical cannabis healthcare and science.”

A medical doctor by background, Castro Alves completed general surgery training in the US and obtained the degree of instructor in advanced trauma life support in Illinois. In Europe, he led Portuguese health regulator Infarmed’s board of directors and assisted numerous medical non-profits.

EXMceuticals appointed Castro Alves in observance of the regime governing the exercise of functions by political officers and senior public officeholders in Portugal, according to the firm.

Summers said that the next step in the company’s strategy is to have a licensed and operating high-quality ingredients factory that will produce to medical standards and have many industrial applications.

EXMceuticals also said that chief strategy officer Marc Bernier was stepping down from the role to move to a consultancy relationship. Bernier was appointed to the company’s board of directors and granted options to purchase 1.5 million shares at C$2 for a ten-year period from the date of grant.

Contact Angela at [email protected]

Follow her on Twitter @AHarmantas

Quick facts: EXMceuticals

Price: 0.49 CAD

CSE:EXM
Market: CSE
Market Cap: $19.44 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of EXMceuticals named herein, including the promotion by the Company of EXMceuticals in any Content on the Site, the Company receives from said...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

EXMceuticals secures critical R&D license for its Portugal cannabis facilities

EXMceuticals Inc's (CSE:EXM) Jonathan Summers speaks to Proactive London's Andrew Scott following the news they've obtained a licence for cannabis research and development from the Portuguese government. The license was granted by INFARMED - the Portuguese National Authority of Medicines and...

on 30/10/19

2 min read